GENEVA, Dec. 31 -- MELT PHARMACEUTICALS, INC. (5511 Virginia Way, Suite 300Brentwood, Tennessee 37027) filed a patent application (PCT/US2025/034126) for "MIDAZOLAM AND KETAMINE FOR ENHANCED SEDATION" on Jun 18, 2025. With publication no. WO/2025/264779, the details related to the patent application was published on Dec 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): DILLAHA, Larry (c/o Melt Pharmaceuticals, Inc.5511 Virginia Way, Suite 300Brentwood, Tennessee 37027)
Abstract: Provided herein are pharmaceutical compositions comprising midazolam and ketamine, and methods of inducing seda...